Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
2,083,186
-
Total 13F shares
-
363,849
-
Share change
-
+129,691
-
Total reported value
-
$232,604
-
Price per share
-
$0.64
-
Number of holders
-
11
-
Value change
-
+$42,616
-
Number of buys
-
5
-
Number of sells
-
5
Institutional Holders of Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB) as of Q3 2025
As of 30 Sep 2025,
Enveric Biosciences, Inc. - Common Stock, par value $0.01 per share (ENVB) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
363,849 shares.
The largest 10 holders included
AdvisorShares Investments LLC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, Tower Research Capital LLC (TRC), BlackRock, Inc., SBI Securities Co., Ltd., BANK OF AMERICA CORP /DE/, NATIONAL BANK OF CANADA /FI/, and WELLS FARGO & COMPANY/MN.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.